Artelo Biosciences Inc (ARTL NASDAQ) stock market data APIs
$10.0442
0.92(9.2%)
as of July 3, 2025
Try our APIs with
free plan!
Artelo Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated/ weight loss with cancer; and ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, pain and inflammation, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Prev. Close
10.0442
Open
10.9618
High
10.9618
Low
9.8915
52 wk Range
4.9176-13.27
Market Cap
5 494 K
Shares Outstanding
547 K
EPS
-0.72
Beta
1.027
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Artelo Biosciences Inc data using free add-ons & libraries
Get Artelo Biosciences Inc Fundamental Data
Artelo Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -7 440 756
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Artelo Biosciences Inc News
New
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Telecoms, Financials and Technology sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Aver...
Artelo Biosciences stock soars after positive first-in-human study results
Investing.com -- Artelo Biosciences Inc (NASDAQ:ARTL) stock surged over 100% following favorable results from its first-in-human study evaluating ART26.12, a novel inhibitor of Fatty Acid Binding Pr...
Sector Update: Health Care Stocks Advance Monday Afternoon
Health care stocks rose Monday afternoon with the NYSE Health Care Index climbing 0.2% and the Healt PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain
First Orally Active Fatty Acid Binding Protein 5 Inhibitor Evaluated in Humans First-in-Class Approach Targets Unmet Need in Multibillion-Dollar Pain Management Market SOLANA BEACH, Calif., June 30...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
